Press/Media
- 1 - 25 out of 1,573 results
Search results
-
BerGenBio ASA: Announces First Patient Dosed in Phase 1b/2a Trial Evaluating Bemcentinib in 1st Line Non-Small Cell Lung Cancer with STK11 Mutations
11/03/23
1 item of Media coverage
Press/Media
-
FABA holding virtual workshop on drug discovery from March 13
11/03/23
1 item of Media coverage
Press/Media
-
-BERGENBIO ANNOUNCES FIRST PATIENT DOSED IN PHASE 1B/2A TRIAL EVALUATING BEMCENTINIB IN 1ST LINE NON-SMALL CELL LUNG CANCER WITH STK11 MUTATIONS
10/03/23
2 items of Media coverage
Press/Media
-
Australia Patent: Icahn School of Medicine at Mount Sinai Files Application for 'Compositions and methods for treating EZH2-mediated cancer'
ANQI MA , Jian Jin & Ramon Parsons
25/03/22 → 10/03/23
2 items of Media coverage
Press/Media
-
Australia Patent: Application for 'Serine threonine kinase (AKT) degradation / disruption compounds and methods of use' Lapses
Xufen Yu, Jing Liu, Ramon Parsons & Jian Jin
10/03/23
1 item of Media coverage
Press/Media
-
-
BerGenBio Announces First Patient Dosed in Phase 1b/2a Trial Evaluating Bemcentinib in 1st Line Non-Small Cell Lung Cancer with STK11 Mutations
9/03/23
73 items of Media coverage
Press/Media
-
Bergenbio Announces First Patient Dosed In Phase 1B/2A Trial Evaluating Bemcentinib In 1St Line Non-Small Cell Lung Cancer With STK11 Mutations
9/03/23
32 items of Media coverage
Press/Media
-
CheckMate 274 follow up data boost nivolumab potential for high-risk bladder cancer
8/03/23
1 item of Media coverage
Press/Media
-
Dr. Galsky on the Rationale for the CheckMate-274 Trial in Urothelial Cancer
8/03/23
1 item of Media coverage
Press/Media
-
Dr. Mascarenhas on the Role of Pacritinib in Myelofibrosis
8/03/23
1 item of Media coverage
Press/Media
-
Scientists Develop Novel Approach to Enhance Drug Delivery for Brain Tumors in …
7/03/23
1 item of Media coverage
Press/Media
-
Icahn School of Medicine at Mount Sinai Reports Findings in Depression (Stress-related reduction of hippocampal subfield volumes in major depressive disorder: A 7-Tesla study)
Gaurav Verma, Hung-Mo Lin, Yael Jacob, Stephanie Brown, Lazar Fleysher, James Murrough, Patrick Hof & Priti Balchandani
7/03/23
1 item of Media coverage
Press/Media
-
Extended Follow-Up Reaffirms Benefit of Adjuvant Nivolumab in Muscle-Invasive Urothelial Carcinoma
7/03/23
1 item of Media coverage
Press/Media
-
Study Results from Icahn School of Medicine at Mount Sinai Update Understanding of Radiation Oncology (The Rise of Open Access Journals in Radiation Oncology: Influence on Resident Research, 2015 to 2019)
Anthony Nehlsen, Eric Lehrer, Stanislav Lazarev, Kunal Sindhu, Brianna Jones & Michael Buckstein
6/03/23
1 item of Media coverage
Press/Media
-
Researchers develop novel approach to enhance drug delivery for brain tumours in children
6/03/23
1 item of Media coverage
Press/Media
-
Study Findings from Icahn School of Medicine at Mount Sinai Advance Knowledge in Radiation Oncology (Gender Differences in the Research Productivity of Radiation Oncology Resident Graduates in the United States: 2015 to 2019)
Anthony Nehlsen, Eric Lehrer, Kunal Sindhu, Sheryl Green, Karyn Goodman & Brianna Jones
6/03/23
1 item of Media coverage
Press/Media
-
Nanoparticles Target Medulloblastoma Tumor to Improve Drug Therapy and Reduce Toxicity
3/03/23
1 item of Media coverage
Press/Media
-
Scientists develop novel approach to enhance drug delivery for brain tumors in children
2/03/23 → 3/03/23
3 items of Media coverage
Press/Media
-
Scientists Develop Novel Approach to Enhance Drug Delivery for Brain Tumors in Children
2/03/23
1 item of Media coverage
Press/Media
-
Mount Sinai Health System: Scientists Develop Novel Approach to Enhance Drug Delivery for Brain Tumors in Children
2/03/23
1 item of Media coverage
Press/Media
-
Risk-Adapted Approach for Muscle-Invasive Bladder Cancer Requires Further Refinement
1/03/23
1 item of Media coverage
Press/Media
-
Studies from Icahn School of Medicine at Mount Sinai in the Area of Personalized Medicine Reported (The Combiome Hypothesis: Selecting Optimal Treatment for Cancer Patients)
Fred Hirsch & Fred Hirsch
27/02/23
1 item of Media coverage
Press/Media
-
Researchers from University of Colorado Provide Details of New Studies and Findings in the Area of Squamous Cell Carcinoma (Egfr High Copy Number Together With High Egfr Protein Expression Predicts Improved Outcome for Cetuximab-based Therapy ...)
Fred Hirsch & Fred Hirsch
27/02/23
1 item of Media coverage
Press/Media